Castle Biosciences, Inc.

CSTL · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$18-$57-$67-$31
Dep. & Amort.$16$12$11$3
Deferred Tax$1-$0-$2-$9
Stock-Based Comp.$50$51$36$22
Change in WC-$14-$7-$0-$4
Other Non-Cash-$7-$5-$19$0
Operating Cash Flow$65-$6-$42-$19
Investing Activities
PP&E Inv.-$28-$14-$6-$3
Net Acquisitions$0$0-$27$0
Inv. Purchases-$206-$189-$135$0
Inv. Sales/Matur.$184$187$0$0
Other Inv. Act.$0$0$1-$63
Investing Cash Flow-$50-$16-$167-$67
Financing Activities
Debt Repay.$10-$0-$0-$0
Stock Issued$2$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$6-$2$2$5
Financing Cash Flow$6-$2$2$5
Forex Effect$0$0$0$0
Net Chg. in Cash$21-$24-$207-$80
Supplemental Information
Beg. Cash$99$123$330$410
End Cash$120$99$123$330
Free Cash Flow$37-$19-$47-$22